Coya Therapeutics, Inc. (COYA)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Proprietary Medicinal Products	3.55M	Log In
Proprietary Medicinal Products Growth	-40.79%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
United States	3.55M	Log In
United States Growth	-40.79%	Log In